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Activation of the interferon type I response
rather than autophagy contributes to
myogenesis inhibition in congenital DM1
myoblasts
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Annalisa Botta7, Monica Evangelista1, Andrea Stoccoro8, Fabio Coppedè8, Denis Furling9 and Marcella Simili5
Abstract
Congenital myotonic dystrophy type 1 (CDM1) is characterized by severe symptoms that affect patients from birth,
with 40% mortality in the neonatal period and impaired skeletal muscle development. In this paper, we examined the
relationship between autophagy and abnormal myogenic differentiation of CDM1 myoblasts. We investigated these
pathological features at both ultrastructural and molecular levels, utilizing two CDM1 foetal myoblasts, CDM13 and
CDM15, with 1800 and 3200 repeats, respectively. The congenital nature of these CDM1 myoblasts was conﬁrmed by
the high methylation level at the DMPK locus. Our results indicated that abnormal autophagy was independent of
myogenic differentiation, as CDM13 myoblasts differentiated as well as control myoblasts but underwent autophagy
like CDM15, displaying impaired differentiation. miRNA expression proﬁles revealed that CDM15 myoblasts failed to
upregulate the complex network of myo-miRNAs under MYOD and MEF2A control, while this network was
upregulated in CDM13 myoblasts. Interestingly, the abnormal differentiation of CDM15 myoblasts was associated with
cellular stress accompanied by the induction of the interferon type 1 pathway (innate immune response). Indeed,
inhibition of the interferon (IFN) type I pathway restores myogenic differentiation of CDM15 myoblasts, suggesting
that the inappropriate activation of the innate immune response might contribute to impaired myogenic
differentiation and severe muscle symptoms observed in some CDM1 patients. These ﬁndings open up the possibility
of new therapeutic approaches to treat CDM1.
Introduction
Myotonic dystrophy type 1 (DM1; MIM#160900) is a
debilitating form of muscular dystrophy due to an
abnormal increase of CTG repeats in the 3′ UTR region of
the dystrophia myotonica protein kinase gene (DMPK).
The disease is autosomal dominant, located on chromo-
some 19, and shows genetic anticipation, meaning that
the disease symptoms tend to be more severe and to
appear at an earlier age as the disorder is passed from one
generation to the next. Indeed, both disease severity and
age of onset correlate with the number of CTG repeats,
ranging from about 100 to 1000 units in adult patients,
and from 1000 to more than 3000 units in the congenital
form (congenital myotonic dystrophy type 1 (CDM1))
that affects patients from birth and is characterized by
severe hypotonia and respiratory insufﬁciency, with
mortality reaching 40% in the neonatal period1. The
mechanism by which the trinucleotide repeats expansion
determines the complex phenotype of this disease has
© The Author(s) 2018
OpenAccessThis article is licensedunder aCreativeCommonsAttribution 4.0 International License,whichpermits use, sharing, adaptation, distribution and reproduction
in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if
changesweremade. The images or other third partymaterial in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to thematerial. If
material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Correspondence: Marcella Simili (marcella.simili@ibf.cnr.it)
1Institute of Clinical Physiology (IFC), CNR, Pisa, Italy
2Istituto Toscano Tumori (ITT), Firenze, Italy
Full list of author information is available at the end of the article.
These authors contributed equally: Milena Rizzo, Pascale Beffy
Edited by G. M. Fimia
Ofﬁcial journal of the Cell Death Differentiation Association
12
34
56
78
90
()
:,;
12
34
56
78
90
()
:,;
1
2
3
4
5
6
7
8
9
0
()
:,;
12
34
56
78
90
()
:,;
recently been partially clariﬁed. One of the most accepted
theories is that the CUG expansion induces abnormal
nuclear accumulation of the mutant mRNA into foci,
which in turn sequester the RNA-binding protein MBNL,
thereby disrupting the normal alternative splicing and
polyadenylation of many mRNAs involved in muscle cell
metabolism (trans-dominant effect)2. However, splicing
changes do not completely explain the DM1 phenotype,
especially the congenital form, as they are shared by other
muscular dystrophies, which do not have the same
symptoms3. In a previous work, we found a profound
impairment in the early steps of muscle differentiation of
DM1 myoblasts with a high number of triplets, accom-
panied by major alterations of signal transduction path-
ways involved in differentiation4. Electron microscopy and
molecular analysis revealed that these myoblasts were
subject to increased autophagy after transfer into differ-
entiating medium, suggesting that autophagy might be an
escape mechanism for myoblasts unable to differentiate
and partially responsible for muscle loss.
In this work, we investigated whether abnormal differ-
entiation and autophagy could be related, and studied the
molecular mechanisms that cause these pathological fea-
tures using two congenital DM1 foetal myoblasts, CDM13
with 1800 and CDM15 with 3200 CTG repeats.
Our results indicated that aberrant autophagy is char-
acteristic of both CDM1 myoblasts independently of their
capacity to differentiate. miRNA proﬁles showed that
CDM15 myoblasts with impaired myogenic differentia-
tion failed to upregulate myo-miRNAs that are under the
control of MYOD and MEF2A. We showed that an
abnormal activation of the interferon (IFN) type 1 path-
way in defective CDM15 myoblasts contributes to altered
myogenesis.
Results
Increased autophagy characterizes both congenital DM1
myoblasts independently of their ability to differentiate
In this study, we used in vitro cell cultures of two DM1
foetal myoblasts (DM15 and DM13) with more than 1000
repeats, and control foetal myoblasts (CON). The repeats
number of DM15 was 3200 CTG;4 DM13 was character-
ized by a combination of LR-PCR and TP-PCR analyses5
as having a 1800 CTG expansion without interruption at
the 5′ or 3′ ends of the repeated array (Supplementary
Fig. 1). As congenital forms of DM1 correlate with high
levels of methylation of the CpG islands ﬂanking the CTG
repeats rather than simply the repeat number,6,7 we
determined the methylation of these regions by the high-
resolution melting (HRM) technique (Fig. 1a, Supple-
mentary Fig. 2). High levels of methylation were found in
the region upstream of the CTG repeats (UR1, UR2, and
UR3 amplicons) of both DM13 and DM15 (see schematic
representation in Fig. 1a), but no methylation was seen in
CON. The amplicons downstream of the CTG repeats
(DR1 and DR2) were hypomethylated in CON and DM1
myoblasts. The methylation and high number of CTG
repeats indicate both DM1 myoblasts to be congenital and
they are henceforth designated as CDM13 (1800 repeats)
and CDM15 (3200 repeats).
Myoblasts were induced to differentiate by shifting sub-
conﬂuent cultures into differentiating medium: CDM13
differentiated as well as CON (about 70% and 80% of
myotubes, respectively, at day 3), while CDM15 myoblasts
differentiated poorly (about 30% of myotubes) (Fig. 1b, c).
We previously hypothesized that autophagy activation
could be the consequence of abnormal differentiation;4
for this reason, CDM13, CDM15, and CON myoblasts
were analyzed by electron microscopy. We found a low
level of autophagy in all analyzed myoblasts both at day 0
and day 3 (Fig. 2g). However, under differentiating con-
ditions (day 3), autophagy increased signiﬁcantly in both
CDM1 myoblasts compared to CON (Fig. 2a–f), mea-
sured as the number of autophagic vacuoles per cell in
both well-differentiated CDM13 and poorly differentiated
CDM15 myoblasts (Fig. 2g). This is clearly visible in
Fig. 2c, where CDM13 myoblasts showed an abundance of
myoﬁbrils, concomitant with numerous autophagic
vacuoles. These results do not support the hypothesis of a
causative association between autophagy and abnormal
differentiation4. Some vacuoles have the typical double
membrane characteristic of autophagosomes (Fig. 2d, f,
black arrow heads), while other more mature autopha-
gosomes, which contain black material, do not show
double membranes8. The small increase of AV diameter
observed at day 3 in comparison to day 0 in all types of
myoblasts (Table 1) could be a reﬂection of a physiolo-
gical increase of autophagy, necessary for differentiation
as reported by Fortini et al.9. However, LC3 activation and
a signiﬁcant ATG5/ATG7 upregulation were found in
CDM13/CDM15 shifted to differentiation medium, but
not in CON (Fig. 3).
An abnormal rough endoplasmic reticulum (RER) with
enlarged cisternae, indicative of cellular stress,10 was
found in CDM15 myoblasts at day 3 (Fig. 4d), unlike
either CDM13 or CON, showing normally shaped RER
(Fig. 4a–c). This result was conﬁrmed by analysis of the
ER stress molecular markers BIP, CHOP, and EDEM
(Fig. 4e), whose mRNA levels only increased signiﬁcantly
at day 3 in CDM15 cells.
Altered expression of MYOD, MEF2A, and muscle
differentiation-related miRNAs in CDM15 myoblasts
To identify molecular pathways involved in defective
myogenic differentiation of CDM15 myoblasts, we pro-
ﬁled global expression of miRNAs (miRNome, data
available at GEO NCBI, GEO accession number
GSE97019) of CON, CDM13, and CDM15 myoblasts
Rizzo et al. Cell Death and Disease          (2018) 9:1071 Page 2 of 16
Ofﬁcial journal of the Cell Death Differentiation Association
before (day 0) and after 3 days in differentiating medium
(day 3). The overall relationship among the miRNomes
was investigated by PCA analysis (Supplementary Fig. 3),
which indicated that CDM13 and CON miRNomes were
similar to one another but differed from CDM15 miR-
Nomes, especially at day 3.
We analyzed miRNAs differentially expressed at both
day 0 (Fig. 5a, Supplementary Table 1) and day 3 (Fig. 5d,
Supplementary Table 2) in CDM15 versus CON and
found 24 miRNAs (9 upregulated and 15 downregulated
miRNAs, |log2FC| > 1, padj ≤ 0.05) at day 0 (named
CDM15vsCON(d0)-miRNAs), and 48 miRNAs (23 upre-
gulated and 25 downregulated miRNAs, |log2FC| > 1,
padj ≤ 0.05) at day 3 (named CDM15vsCON(d3)-miR-
NAs). We also checked the expression levels of
CDM15vsCON(d0)- and CDM15vsCON(d3)-miRNAs in
CDM13 at day 0 (Fig. 5a, third column) and day 3 (Fig. 5d,
third column) miRNomes and found that the expression
level of CDM15vsCON-miRNAs in CDM13 was com-
parable to that found in CON, suggesting that the
miRNAs altered in CDM15 were normally expressed
in CDM13.
To clarify the possible functional role of
CDM15vsCON-miRNAs we examined the pathways in
which their target genes are involved.
For the CDM15vsCON(d0)-miRNAs, we focused only
on the validated targets from well-annotated databases
(e.g. MirTarBase, miRecords) and found that 124
KEGG pathways were signiﬁcantly enriched (p ≤ 0.05,
Supplementary Table 3). Interestingly, some of the
CDM15vsCON(d0)-miRNA targets belonged to pathways
necessary for differentiation. Thus, the upregulation of
Fig. 1 Characterization of CDM1 myoblasts. a High-resolution melting analysis of the DMPK locus. Percentage of methylation in the region upstream
(UR1-UR3, left side) and downstream (DR1-DR2, right side) of the CTG repeats at the DMPK locus of CON, CDM13, CDM15 (upper panel), and
schematic representation of the regions analyzed at the DMPK locus (lower panel). b Images of control (CON) and of the two CDM1 myoblasts,
CDM13 (1800 repeats) and CDM15 (3200 repeats) after 3 days in differentiation medium (Giemsa staining). c Percentage of myotubes obtained by
dividing the number of myotubes (cells with more than three nuclei) by the number of counted nuclei (at least 1000 nuclei for each time point). The
average number of nuclei per myotube, evaluated by counting a total of 500 myotubes, is reported in brackets above each column
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Fig. 2 Analysis of autophagic vacuoles by transmission electron microscopy. Representative micrographs of autophagic vacuoles (AV) in CON (a, b),
CDM13 (c, d), and CDM15 myoblasts (e, f) after 3 days in differentiation medium. g Average number mean (±SE) of AV/cell determined by counting
the AV in at least 50 myoblasts. The signiﬁcance was calculated with the multifactor analysis of variance, MANOVA (***p < 0.001). GLY glycogen
particles, MYO myoﬁbers, AV autophagic vacuoles, N nucleus, RER rough endoplasmic reticulum. Arrow heads indicate the vacuole double
membranes
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miR-10b-5p and miR-143-3p, which target PI3K and
IGF1R/AKT, respectively, as well as that of miR-10b-3p
and miR-145-5p, which target IGF1R (Fig. 5b), could
contribute to the inhibition of the mTOR pathway, whose
activation is required for differentiation11 (Supplementary
Table 4). Indeed, the AKT level of CDM15 at day 0 is
slightly but signiﬁcantly lower than in control myoblasts,
supporting the hypothesis that miR-143-3p upregulation
might be involved in AKT decrease (Fig. 5c). In accor-
dance with this result, p-S6K1 phosphorylation level is
lower in CDM15 both at day 0 and day 3 in comparison to
CON and CDM13 (Supplementary Fig. 4) as previously
shown4. It is worth noting the miR-206, required for
differentiation12,13, was downregulated in CDM15 myo-
blasts compared to CDM13/CON myoblasts, supporting
the hypothesis of an early commitment of CDM13 toward
differentiation that is lacking in CDM15 myoblasts.
As expected, many of the CDM15vsCON(d3)-miRNAs
play a major role in muscle differentiation (the so-called
myo-miRNAs, Fig. 5d, underlined miRNAs)12. We vali-
dated two important myo-miRNAs, miR-1-3p, and miR-
206, by qRT-PCR (Fig. 6a, b): as expected, both miRNAs
were poorly induced in CDM15, while they progressively
increased in CON/CDM13, reaching a peak at day 3.
Since these miRNAs are regulated by MYOD12,13, we
veriﬁed the relative MYOD expression. As expected
(Fig. 1), MYOD was poorly induced in CDM15 (Fig. 6c, d)
while it increased in both CDM13 and CON myoblasts
with a time course matching that of miR-1-3p and miR-
206. To investigate whether other deregulated miRNAs
could play a role in myogenesis, we identiﬁed the vali-
dated targets of all CDM15vsCON(d3)-miRNAs and
searched for those belonging to the myogenesis pathway
(id: R-HSA-525793) present in the REACTOME db
(http://www.reactome.org/) (Supplementary Table 5).
This approach highlighted the downregulation of miR-
433, miR-495-3p, and miR-410-3p belonging to the Gtl2-
Dio3 miRNA mega cluster, fundamental for skeletal
muscle regeneration14 and controlled by MEF2A, and the
upregulation of miR-155-5p, known to target MEF2A15.
Indeed, we found that MEF2A was signiﬁcantly down-
regulated (Fig. 6f), while miR-155-5p was upregulated
(Fig. 6e), at day 3 in CDM15 versus CON/CDM13.
Overall these results indicated that the expression of a
number of miRNAs involved in myogenesis was impaired
in CDM15 myoblasts.
Activation of IFN type 1 response in CDM15 myoblasts
Analysis by electron microscopy revealed that CDM15
myoblasts showed not only autophagic vacuoles but also a
remarkably stressed RER (Fig. 4d) compared to CDM13/
CON. p53 increase16 in CDM15 (Supplementary Fig. 5)
also suggested the presence of a marked cellular stress in
these myoblasts not present in CDM13. Different toxic
stimuli could be the basis of CDM15 cellular stress: it has
been shown that toxic RNAs containing CUG repeats
accumulate in the nuclei of DM1 myoblasts (foci)2,17, and
that this RNA can give rise to dsRNA structures18. It is
known that dsRNA elicits IFN type 1 (IFN1) production,
which activates the innate immune response in an auto-
crine fashion19. We hypothesized that dsRNA structures,
produced by transcription of the mutant DMPK allele,
might induce an IFN response, as previously proposed20,
and inhibit muscle differentiation21.
For this reason we analyzed IRF7, one of the ﬁrst
induced IFN1-positive regulators22, as well as some of the
IFN1-upregulated genes such as STAT123, and the three
2′–5′ oligoadenylate synthetase genes (OAS 1, OAS 2, and
OAS 3)24, and found that their levels markedly increased
in CDM15 versus either CON or CDM13 myoblasts
(Fig. 7a-e). Finally, as IFN1 is known to induce the release
of inﬂammatory cytokines25, we measured mPGES-1 and
found a marked increase in CDM15 myoblasts shifted to
differentiation medium (Fig. 7f), as previously published26.
Altogether, these results suggest that CDM15, upon
exposure to differentiation medium, undergo a marked
upregulation of the IFN1 pathway, which could be directly
or indirectly causatively correlated with the inhibition of
differentiation observed in these myoblasts.
It has recently been reported that an increase of the
sense DMPK transcription coupled with the reduction of
DMPK antisense transcription was responsible for the
enhanced production of toxic dsRNA formation in
patients with severe CDM27. We checked the levels of the
two transcripts in all three myoblasts and found that the
level of DMPK sense transcript appeared to be higher
than that of the antisense transcript in CDM13/CDM15
myoblasts (day 3), with the ratio sense/antisense being
Table 1 Diameter (mean±SD) of autophagic vacuoles
(AV)
AV diameter (µm)
CON
Day 0 0.68 ± 0.23
Day 3 1.13 ± 0.32
CDM13
Day 0 0.90 ± 0.25
Day 3 1.33 ± 0.55
CDM15
Day 0 0.66 ± 0.33
Day 3 1.16 ± 0.44
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very similar in both CDMs and higher than in control
myoblasts (Supplementary Fig. 6). These results, while in
keeping with the hyper-methylation of the upstream CTG
region in CDM1 patients, do not explain the different
degree of differentiation observed in CMD13/CDM15
myoblasts.
As the upregulation of the IFN1 pathway in CDM15
myoblasts correlated with impaired myogenesis, we
silenced two genes known to control this pathway at two
different levels: (i) Toll-like receptor 3 (TLR3), which is
part of a family of receptors28 that recognize dsRNA and
as such controls one of the early steps of the pathway; (ii)
IRF7, considered to be one of the master regulators of
IFN1, acting downstream of TLR329 and markedly upre-
gulated in CDM15 at day 3 (Fig. 7a). We transfected
CDM15/CON myoblasts with siRNAs against IRF7 or
TLR3 and then shifted them in differentiating medium for
3 days: at this time point the IRF7 and TLR3 mRNA levels
were strongly reduced (Supplementary Fig. 7). The silen-
cing of IRF7 and, to a lesser extent, TLR3 partially rescued
the defective CDM15 differentiation as shown by the sig-
niﬁcant increase of myotubes formation in terms of
number of myotubes and nuclei per myotube (Fig. 8b) at
day 3. Restored myogenesis of CDM15 myoblasts was
accompanied by an increase of MYOD (Fig. 8c) and
MEF2A (Fig. 8e) and a strong decrease of OAS1 (Fig. 8d).
Fig. 3 Analysis of proteins involved in autophagy. Representative LC3, ATG5, and ATG7 protein quantiﬁcations by immunoblot analysis of CON,
CDM13, and CDM15 myoblasts before and after exposure to differentiation medium (days 0–5). LC3 activation was determined by calculating the
ratio between the cleaved active LC3-II form and the non-active LC3-I form. The levels of ATG5 and ATG7 were normalized to that of αtubulin. All
data were reported in the corresponding histogram. Results are expressed as mean (SD) and data analyzed by Student’s t-test (*P < 0.05, **P < 0.01,
***P < 0.001). The signiﬁcance was calculated in CDM13 or CDM15 versus CON for each day
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We also tested the miR-155-5p levels, as this miRNA
could be under the control of IFN1. Although miR-155-5p
tended to decrease after TLR3 or IRF7 silencing in
CDM15 myoblasts, the variations were not signiﬁcant
(Fig. 8f); this suggests that in this context miR-155-5p is
neither controlled by IFN1 nor controls MEF2A.
Discussion
We had previously shown that CDM15 foetal myoblasts
with high number of repeats (> 3000) did not differentiate
properly and underwent autophagy, but the molecular
mechanisms underlying this behavior were not fully
investigated, nor was it clear whether autophagy was
causatively related to aberrant differentiation4. To better
investigate these aspects we included in our study another
congenital foetal DM1 myoblast, CDM13, containing
1800 repeats and found that their behavior, concerning
differentiation, were totally different: CDM15 differ-
entiated poorly (as previously reported4), whereas CDM13
differentiated like control myoblasts.
Fig. 4 Analysis of the rough endoplasmic reticulum (RER). Representative micrographs of normal RER observed with transmission electron
microscopy at day 3 in CON (a, b) and CDM13 (c), and of very enlarged RER present in CDM15 myoblasts (d). GLY glycogen particles, MYO myoﬁbers,
AV autophagic vacuoles, N nucleus, RER rough endoplasmic reticulum. e Relative BIP, CHOP, EDEM mRNA expression levels, quantiﬁed by qRT-PCR, in
CON, CDM13, and CDM15 on day 3. Data were normalized using the geometric mean of three reference genes (GUSB, TBP, and RPS18). Results are
expressed as mean (SD) of at least three independent experiments and data analyzed by Student’s t-test (*P < 0.05, **P < 0.01, ***P < 0.001). The
signiﬁcance was calculated in CON, CDM13, or CDM15 day 3 versus the corresponding day 0
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Because miRNA expression plays a major role in muscle
development and dysfunction12, a global miRNA expres-
sion proﬁle (miRNome) was performed for the ﬁrst time
on foetal CDM1 and control myoblasts.
The miRNA proﬁles showed a severe deregulation of
the miRNAs, that control myogenesis (myo-miRNAs),
reﬂecting the defective differentiation observed in
CDM15 myoblasts. Moreover, miRNA deregulation might
be an early event present at the time of commitment
toward differentiation since some of the miRNAs
deregulated at day 0 in CDM15 can predict the inhibition
of the differentiation program. For instance, miR-10b-5p,
miR-145-5p, and miR143-3p, which target important
mediators of the mTOR pathway essential for myogen-
esis11, were upregulated, while miR-206, one of the most
important myo-miRNAs12,13, was downregulated. As
Fig. 5 miRNA proﬁle and validation. Heat map of miRNAs differentially expressed in CDM15 versus CON at day 0 (CDM15vsCON(d0)-miRNAs) (a) and
at day 3 (CDM15vsCON(d3)-miRNAs) (d): the expression level of these miRNAs was also checked in CDM13 (third column). Relative miR-10b-5p, -10b-
5p, -143, -145-5p (b) and AKT protein (c) expression levels in CON, CDM13, and CDM13 at day 0 . Data were normalized using U6 or αtubulin for
miRNAs and AKT protein, respectively. Results are expressed as mean ± SD of at least three independent experiments and data analyzed by Student’s
t-test (*P < 0.05, **P < 0.01, ***P < 0.001) . The signiﬁcance was calculated in CDM13 or CDM15 day 0 versus CON day 0
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expected, the most signiﬁcant differences between
CDM15 and CDM13/CON were found at day 3, when the
differentiation program is fully activated and many of the
so-called myo-miRNAs were induced in the two types of
differentiating myoblasts (CON/CDM13) but not in
CDM15 (Fig. 5d). In line with these results, CDM15
myoblasts shifted to differentiation medium were unable
to upregulate MYOD, one of the master myogenic
transcription factors that controls miR-1-3p, miR-133a-
3p, miR-133b, and miR-206 expression. Interestingly,
Amack et al.30 reported that defective myogenic differ-
entiation of C2C12 murine myoblasts expressing expan-
ded CTG repeats was associated with an absence of
MYOD at the protein level although MYOD mRNA
expression was normal. On the contrary, we found that in
CDM15 MYOD was poorly induced both at the protein
Fig. 6 Expression analysis of miRNAs and genes related to differentiation. Relative expression level quantiﬁcation determined by qRT-PCR of miR-1-3p
(a), miR-206 (b), MYOD mRNA (c), and protein (d) during the exposure to differentiation medium (days 0––5) and of miR-155-5p (e) and MEF2A (f) at
day 3. The relative expression was evaluated with respect to CON at day 0 for (b–d) and with respect to CON at day 3 for (e) and (f). Data were
normalized using U6, αtubulin or the geometric mean of three reference genes (GUSB, TBP and RPS18) for miRNAs, proteins and MYOD/MEF2A mRNAs
respectively. Results are expressed as mean ± SD of at least three independent experiments and data analyzed by Student’s t-test (*P < 0.05, **P <
0.01, ***P < 0.001). The signiﬁcance was calculated in CDM13 or CDM15 versus CON for each day
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and mRNA levels, possibly due to increased mRNA decay,
although inhibition of transcription cannot be ruled out.
Some of the miRNAs (Fig. 5d) belonging to the Gtl2-
Dio3 miRNA mega cluster, fundamental for skeletal
muscle regeneration14 and controlled by MEF2A, were
downregulated, suggesting that, along with MYOD, the
MEF2A transcription network of CDM15 myoblasts
might also be altered. Finally, we wish to point out that 10
out of 23 upregulated miRNAs in CDM15vsCON(d3)
(miR-199a, -145, -143, -28, -221-3-p, -221-5-p, -222-3p,
-222-5p, -100, -155) were also found upregulated in many
primary muscular disorders including Duchenne mus-
cular dystrophy31.
Our data indicate that a marked increased autophagy
and aberrant differentiation are not necessarily connected.
Indeed, CDM13, which differentiated as well as control
myoblasts, underwent increased autophagy to the same
extent as CDM15 myoblasts. We wish to point out that in
our system two levels of autophagy induction were evi-
dent: a physiological and an aberrant one. In all tested
myoblasts, we found autophagic vacuoles at day 0
undergoing an enlargement by day 3, indicating that a
certain increase of autophagy takes place as a “physiolo-
gical” mechanism necessary for differentiation9. As far as
LC3 activation is concerned we did not observe any
activation in CON myoblasts at day 3, as previously
Fig. 7 Analysis of interferon type 1 pathway. Relative expression level quantiﬁcation of IRF7 (a), STAT1 (b), OAS1 (c), OAS2 (d), OAS3 (e), and mPGES-1 (f)
after the exposure to differentiation medium (days 0–5). The relative expression was evaluated with respect to CON at day 0. Data were normalized
and analyzed as described in ﬁgure 6, and were expressed as mean ± SD of at least three independent experiments
Rizzo et al. Cell Death and Disease          (2018) 9:1071 Page 10 of 16
Ofﬁcial journal of the Cell Death Differentiation Association
Fig. 8 Myogenic differentiation after IRF7 and TLR3 silencing. (a) Images of CON, CDM13, and CDM15 myoblasts exposed to three days of
differentiation medium after IRF7 (siIRF7), TLR3 (siTLR3), and control (siCT) silencing (dd3) (Giemsa staining). (b) Percentage of myotubes and average
number of nuclei per myotube in CON and CDM myoblasts at dd3 evaluated as described in Fig. 1. Relative expression level of MYOD (c), OAS1 (d),
MEF2A (e), and miR-155-5p (f) in CON, CDM13, and CDM15 myoblasts dd3 versus the respective dd0 (dd0 is the time point after the end of
transfection and before the exposure to differentiation medium). Normalization and statistical analysis were done as described in Fig. 6. The
signiﬁcance was calculated in siIRF7 dd3 and siTLR3 dd3 samples versus siCT dd3
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reported in another human control foetal myoblast4. LC3
activation was only visible in CDM1 myoblasts con-
comitant with an abnormal increase of autophagy, which
appears to be independent from differentiation as it also
occurs in aberrantly differentiating CDM15. This patho-
logical increase of autophagy could contribute to the
marked reduction of muscle mass observed in CDM1
patients, a feature that has been also reported in DM1
patients32.
Finally, our study indicated that the abnormal differ-
entiation observed in CDM15 myoblasts was associated
with p53 upregulation, the presence of a stressed RER,
and the activation of the IFN1 pathway. The ﬁndings that
the IFN1-positive regulator IRF7, the downstream effector
STAT1 and the IFN1-regulated genes OAS 1, OAS 2, and
OAS 3, increased many fold in CDM15 compared to
CON/CDM13 indicated a marked upregulation of IFN1
pathway (innate immune response). The product of the
induced OAS enzymes is the small oligonucleotide 2′–5′
oligo A, which in turn activates the latent endor-
ibonuclease RNase L, leading to degradation of RNA
including cellular mRNAs33. Therefore, the activation of
the interferon pathway and the consequent upregulation
of the OAS gene family in CDM15 myoblast, could be
responsible for the poor induction of MYOD mRNA.
Interestingly, the activation of the 2′–5′ oligoadenylate/
RNase pathway has been shown to delay C2C12 myo-
blasts differentiation via degradation of MYOD mRNA34.
Activation of interferon-regulated genes has been
observed in lens epithelium from DM1 patients35. These
authors hypothesized that toxic dsRNAs containing
expanded CUG repeats might trigger the IFN1 response,
analogously to RNA viruses. Although mutant mRNA is
usually localized in foci within the nucleus of
DM1 cells2,17, these foci undergo dynamic changes during
the cell cycle (mitosis), resulting in cytoplasmic localiza-
tion20 where dsRNA could be detected by dsRNA-speciﬁc
receptors (such as the Toll-like receptor 3, TLR3)36 and
induce the IFN1 pathway. As the activation of IFN1
response in CDM15 appeared to be causatively correlated
to myogenesis inhibition, we tried to inhibit this response
by silencing two genes acting at different levels of the
IFN1 pathway, namely TLR3 and the downstream master
regulator of IFN1 IRF729, strongly upregulated in CDM15.
Interestingly, the transient silencing of the two genes
before shifting CDM15 into differentiating medium sig-
niﬁcantly ameliorated myogenesis, measured as the
numbers of myotubes, without detectable effects in CON
myoblasts. It is noteworthy that IRF7 silencing induced a
number of myotubes comparable to control and a sig-
niﬁcant increase of MYOD and MEF2A mRNAs, the two
transcription factors essential for myogenesis; con-
comitantly, there was a drastic reduction of OAS1, as
expected if IFN1 was inhibited. These data conﬁrm the
powerful contribution of the IFN1 pathway activation to
the impairment of myogenesis in CDM15 myoblasts.
However, while the silencing of both IRF7 and TLR3
appear to be efﬁcient, the rescue of differentiation was
more pronounced after IRF7 inhibition. A possible
explanation is that TLR3 is not the only member of the
Toll-like receptors family responding to dsRNA37 and
hence its inhibition may not result in the total reduction
of dsRNA sensors. Finally, the inhibition of the IFN1
pathway did not signiﬁcantly change miR-155-5p level,
suggesting that in this context this miRNA is neither
controlled by the IFN1 pathway nor does it regulate
MEF2A.
Interestingly, the hyper-methylation of the CTCF I
regions of CDM15/CDM13 myoblasts correlated with
decreased DMPK antisense transcription in both CDM,
suggesting that in our case, unlike the report of Nakamori
et al.27, the transcriptional deregulation of sense/antisense
transcription does not explain the more severe phenotype
of CDM15.
At present, we can only speculate why CDM13 myo-
blasts do not activate the IFN1 response. We did not ﬁnd
any interspersed repeats in the CTG tract of CDM13 that
could have explained the less severe phenotype. However,
these myoblasts did not show signs of cellular stress
during differentiation (enlarged RER and p53 upregula-
tion) as found in CDM15. One possible explanation is that
the 1800 GUG sequence in CDM13 does not form stable
toxic dsRNA structures. The other possibility is that the
majority of dsRNAs remain localized in the nucleus, never
reaching the cytoplasm to activate the innate immune
response.
In conclusion, our data show for the ﬁrst time the
miRNA proﬁle of human CDM1 and control foetal
myoblasts, and conﬁrm the relevance of miRNAs in
myogenesis. Our results suggest that the congenital
phenotype, ascertained by triplet numbers and
methylation pattern, could be more complex than
expected to the extent that IFN1 activation might play
a role in severe muscle pathogenesis, while yet
unclariﬁed mechanisms might lead to a less severe
phenotype than predicted by current criteria (see
CDM13). The results of silencing the IFN1 pathway are
signiﬁcant as they show rescue of aberrant myogenesis
in CDM1 myoblasts; hopefully these in vitro results
may lead to a better understanding of the molecular
basis of this disease and identify potential targets in the
search for innovative therapies.
Methods
Cell culture
Human myoblasts isolated from muscle biopsies
obtained during autopsies of fetuses were obtained
according to previously described methods38. Control and
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CDM1 myoblasts with 1800 CDM13 and 3200 CDM15
repeats, respectively, were utilized at early passages (p 4)
in order to avoid senescence. Myoblasts were seeded at a
density of 12,000 cells/cm2 in HAM’s/F10 medium sup-
plemented with 50 µg/ml fetuin, 5 µg/ml insulin, 10 ng/ml
EGF, 0.5 mg/ml BSA, and 20% FBS (Euroclone). Medium
was changed every day. When cells reached about 80%
conﬂuence (40,000–50,000 cells/cm2), differentiation to
myotubes was induced by incubating the cells into a
serum-free MEM (Euroclone) supplemented with 10 µg/
ml insulin and 0.5 mg/ml BSA. The number of myotubes
(i.e. myoblasts with more than three nuclei) and the
number of nuclei per myotube were evaluated after
Giemsa staining.
Genotyping of the CDM13 myoblasts
Genomic DNA was extracted from myoblasts using a
salting-out procedure. (CTG)n repeat expansion sizes
were determined by long-PCR (LR-PCR), followed by
hybridization with a (CTG)5 radioactively labelled
probe39. Primers used for LR-PCR are indicated in Sup-
plementary Table 6. Bidirectional TP-PCR analysis was
also performed to exclude the presence of interruptions at
the 5′ and 3′ ends of the CTG array5.
Methylation-sensitive high-resolution melting (MS-HRM)
Two hundred nanograms of DNA isolated with
DNAeasy blood and tissue kit (Qiagen) were treated
with EpiTech Bisulﬁte kit (Qiagen) according to the
manufacturer's instruction. The high-resolution melt-
ing analysis was performed using the CFX96 thermal
cycler (Biorad). The primers used for the HRM analysis
were described in Santoro et al.6 with some modiﬁca-
tions (Supplementary Table 6). The reaction mix (total
volume 10 µl) contained 0.5 µM primers (Euroﬁn), 5 µl
EpiTect HRM master mix (Qiagen), and 10 ng of
treated DNA. The PCR conditions were as follows: an
initial denaturation at 95 °C for 12 min, 60 cycles of 30 s
denaturation at 95 °C, 30 s of annealing, and 30 s of
extension at 72 °C, followed by an HRM step of 95 °C
for 10 s, 50 °C for 1 min, 65 °C for 15 s, and continuous
acquisition to 95 °C at one acquisition per 0.2 °C.
Annealing temperatures used for UR1, UR2, UR3, DR1,
and DR2 MS-HRM analyses were 63.3, 59, 63.3, 55, and
55.7 °C, respectively. For the UR3 region the HRM
protocol was applied after a pre-ampliﬁcation step
performed with GoTaq DNA polymerase (Promega)
using 20 ng bisulﬁte-treated DNA in 25 µl ﬁnal volume
with the following PCR conditions: 5 min of an initial
denaturation step at 95 °C, 40 cycles of 30 s 95 °C, 30 s
58 °C, 30 s 72 °C and a ﬁnal step at 72 °C for 5 min. Fully
methylated and unmethylated DNA (EpiTect methy-
lated and unmethylated human control DNA, bisulﬁte
converted, Qiagen) was mixed to obtain the following
ratios of methylation: 0%, 12.5%, 25%, 50%, 100%.
In order to obtain single methylation percentage
values from MS-HRM assays, rather than a range, we
applied an interpolation method developed in our
laboratory40.
Western blot analysis
Cell lysates were prepared as previously described4.
Samples were loaded on 10–12% polyacrylamide gels and
then transferred to nitrocellulose membranes (Amersham
Biosciences). The blots were blocked with 5% skimmed
milk (Amersham) in TBST. Anti-ATG5 (A0856) (1:2000),
anti-ATG7 (A2856) (1:1000), anti-LC3I-II (L8918)
(1:1500), anti-αtubulin (T5168) (1:8000) obtained from
Sigma, and anti-p53 (DAKO, M1001) (1:2000), anti-p-
p70S6 kinase (p-S6k1) (Santa Cruz, sc-7984-R) (1:500)
and anti-AKT (Cell Signalling, 9272) (1:1000) were used.
Incubations were performed overnight at 4 °C and bands
were revealed, after incubation with the recommended
secondary antibody by the chemiluminescence method
(Amersham) with X-OMAT ﬁlm (Kodak). Densitometric
analysis of developed blots was performed with the
Quantity One program. Results are expressed as mean ±
SD of at least three independent experiments and data
analyzed by Student’s t-test (*P < 0.05, **P < 0.01, ***P <
0.001).
Electron microscopy analysis
Myoblasts from each experimental group were ﬁxed
in 2.5% glutaraldehyde in 0.1 M phosphate buffer, pH
7.3, for 20 min at room temperature, washed in the
same buffer, and postﬁxed in 1% osmium tetroxide in
0.1 M phosphate (pH 7.3) for 1 h at room temperature,
and dehydrated in graduated series of ethanol. During
the last dehydration step, the cells were scraped and the
cell suspensions were centrifuged to obtain pellets.
These pellets were then transferred into propylene
oxide and embedded in PolyBed 812 (Polyscience Inc.,
Warrington, PA, USA) and polymerized at 60° for 72 h.
Ultrathin sections (60–80 nm), obtained with a
Reichert-Jung Ultracut E (Austria) equipped with a
diamond knife, were collected on 200-mesh formar/
carbon-coated copper grids, double stained with aqu-
eous uranyl acetate and lead citrate, and examined with
a Jeol 100 SX transmission electron microscope oper-
ating at 80 kV.
Morphometric analysis: assessment of autophagic
vacuoles
In our experimental setting, we took advantage of
cellular pellets because ultrathin sections contain ran-
domly oriented cells, which is an appropriate condition
for quantitative calculation41,42. For ultrastructural
morphometry non-serial ultrathin sections were
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obtained for each experimental group as described
above. Ultrathin sections were examined directly at the
transmission electron microscopy at 5000X magniﬁca-
tion in order to estimate the number of autophagic
vacuoles (AV) per cell. AVs were identiﬁed as double-
membraned structures (compartments) containing
altered cytoplasmic organelles or cytosolic material43.
At least three grids were examined for each experi-
mental group and 50 cells were scored for each sample.
For the diameter evaluation, a minimum of 100 vacuoles
were examined at each time point. The comparison
among groups was performed with the multifactor
analysis of variance, MANOVA. The vacuole diameter
(Table 1) was determined using ImagJ. A minimum of
25 myoblasts were selected and at least 100 vacuoles
were examined. The signiﬁcance was determined by
ANOVA.
siRNAs transfection
CON, CDM13, and CDM15 myoblasts were transfected
in six-well plate format with lipofectamine RNAiMAX
(Life Technologies) using siTLR3 (TLR3 silencer selected
validate siRNA, s235, Ambion), siIRF7 (IRF7 silencer
selected pre-designed siRNA, s194563, Ambion), and
siCT (silencer negative control, 4390843, Ambion) as
control. Cells were transfected with 6 µl of lipofectamine
and 25 pmol of siRNAs following the manufacturer's
instruction. After 10 h (dd0) the medium was changed
and cells exposed to differentiation medium for 3 days
(dd3).
Quantiﬁcation of miRNAs and mRNAs (qRT-PCR)
Total RNA was extracted from 1 × 106 myoblasts
using the miRNeasy mini kit (Qiagen) following the
manufacturer’s recommendations. One microgram of
total RNA was retrotranscribed using either the miS-
cript II RT kit (Qiagen) or the SuperScript-VILO
cDNA Synthesis Kit (Invitrogen) for miRNAs or
mRNAs quantiﬁcation, respectively. The reverse tran-
scription was performed following the manufacturer’s
instructions. miRNAs and mRNAs were quantiﬁed
with Rotor-Gene Q 2plex (Qiagen), using the miScript
SYBR Green PCR Kit (Qiagen) according to the pro-
tocol indicated by the manufacturer. The relative
quantiﬁcation was performed using the Rotor-Gene Q
Software, normalizing to the internal controls: U6 was
used for miRNAs and the geometric mean of three
reference genes (GUSB, TBP, and RSP18)44,45, whose
expression did not change signiﬁcantly during myo-
blasts differentiation, was used for mRNAs. Results are
expressed as mean ± SD of at least three independent
experiments and data analyzed by Student’s t-test (*P <
0.05, **P < 0.01, ***P < 0.001). The primers used are
shown in Supplementary Table 6.
The quantiﬁcation of DMPK sense/antisense tran-
scripts level was performed as described by Michel
et al.46 with some modiﬁcations. Brieﬂy, total
RNAs were retrotranscribed with QuantiTect Reverse
Transcription kit (Qiagen) using speciﬁc primers for
sense and antisense retrotranscription. The relative
levels of sense or antisense transcripts were normalized
to the mean of three reference genes as explained
above.
miRNA proﬁling with next generation sequencing (NGS)
technology (smallRNA-seq)
NGS was performed on RNA extracted from two bio-
logical replicates of CON, CDM13, and CDM15 myo-
blasts at day 0 and at day 3, before and after shift into
differentiation medium. The cDNA libraries were con-
structed using TrueSeq Small RNA kit (Illumina)
according to the manufacturer’s suggestions. cDNA
libraries were loaded at six-plex level of multiplexing (~4
million reads per sample) into a V3 ﬂow cell, and
sequenced in single-reads mode (50 bp) on a MiSeq
sequencer (Illumina).
NGS data analysis
Pre-miRNA sequences from miRBase v.21 (http://www.
mirbase.org/) were identiﬁed from raw sequences as
previously described47 using miRExpress tool v.2.1.348.
The miRNomes of each sample were analyzed using
Bioconductor’s package DESeq249. Speciﬁcally, the origi-
nal raw count data were ﬁrst scaled for library size factors
and regularized log transformed (rlog function) for the
principal component analysis, then they were used to test
for differential expression after per gene dispersion esti-
mation. A fold change (FC) of 2 was used to select
modulated miRNAs, with P-adjusted for multiple testing
< 0.05 (Benjamini and Hochberg procedure).
Target genes and pathways analysis
To identify genes that are targets of modulated miRNAs
and to investigate altered pathways in CON, CDM13, and
CDM15 myoblast cells we exploited the miRNet web-
based tool (http://www.mirnet.ca)50. MiRNet includes a
comprehensive collection of high-quality and experi-
mentally validated miRNA-target interaction data from 11
databases. We identiﬁed targets of modulated miRNAs
and performed their functional enrichment analysis for
KEGG and Reactome pathways using the more suitable
empirical sampling-based approach described by Bleazard
et al.51 and implemented by miRNet. This method is more
suitable for miRNAs-target genes since it takes into
account the fact that each miRNA has the potential to
target hundreds of different genes, while common
enrichment analysis methods assume that genes are
selected uniformly at random from a ﬁnite population. A
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p-value ≤ 0.005 was considered statistically signiﬁcant in
this case.
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